CELL AND GENE THERAPY INSIGHTS

August 2023 Issue

Volume 9 Issue 7

Cell and Gene Therapy Insights Volume 9 Issue 7

Featuring

Issue Spotlight: New horizons in immunotherapy
Supply Chain focus: Driving the digitization of cell and gene therapy supply chains 2023
Other articles
Webinars

SPOTLIGHT

New horizons in immunotherapy
David Morrow
Guest Editor:
David Morrow, Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS

Editorial

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

E Oldoni, P Carvajal-Vallejos, F Bietrix et al.
11 August 2023
Read

Expert Insight

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Lauren Sarko, Krishanu Saha
14 September 2023
Read

Viewpoint

iNKT cells for allogeneic cell therapy

iNKT cells for allogeneic cell therapy

Eleni Chantzoura, Paul Ibbett
31 August 2023
Read

Interview

Developing universal AAV immuno-gene therapy for oncology

Developing universal AAV immuno-gene therapy for oncology

Nicole Paulk
24 August 2023
Read
Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Ming-Ru Wu
21 August 2023
Read
Rearming the immune system with personalized allogeneic CAR-T cell therapy

Rearming the immune system with personalized allogeneic CAR-T cell therapy

Olivier Negre
18 August 2023
Read
Increasing patient access to cellular immunotherapy through RNA gene writing

Increasing patient access to cellular immunotherapy through RNA gene writing

Madhusudan Peshwa
5 August 2023
Read

Supply Chain FOCUS

Driving the digitization of cell and gene therapy supply chains 2023

Commentary

Cell and gene therapy commercial off-the-shelf software components

Cell and gene therapy commercial off-the-shelf software components

Parris Farr
23 August 2023
Read

Journal articles

Innovator Insight

Overcoming upstream & downstream process barriers for large-scale AAV production

Overcoming upstream & downstream process barriers for large-scale AAV production

Betty Woo, Jonathan Zmuda
8 September 2023
Read
Addressing regulatory guidance for HEK293 cells & AAV-based therapeutics manufacturing

Addressing regulatory guidance for HEK293 cells & AAV-based therapeutics manufacturing

Michael Brewer
23 August 2023
Read
Future-proof your AAV process with a complete producer cell line

Future-proof your AAV process with a complete producer cell line

Dovile Gruzdyte
10 August 2023
Read

FastFacts

Developing oligonucleotide therapeutics with confidence

Developing oligonucleotide therapeutics with confidence

Lucy Cook
6 August 2023
Read

Infographic

Residual DNA testing: Homebrew vs off-the-shelf solutions: INFOGRAPHIC

Residual DNA testing: Homebrew vs off-the-shelf solutions: INFOGRAPHIC

17 August 2023
Read

Webinar Digest

Advancing the purification of VSV-G pseudotyped lentiviral vectors by using affinity chromatography

Advancing the purification of VSV-G pseudotyped lentiviral vectors by using affinity chromatography

Pim Hermans, Frank Detmers
11 August 2023
Read

Poster

Navigating evolving regulatory CMC guidance in the AAV gene therapy field

Navigating evolving regulatory CMC guidance in the AAV gene therapy field

M Brewer, A Cockroft, C Fuentes et al.
24 August 2023
Read

Viewpoint

Leading a gene therapy team to market approval success

Leading a gene therapy team to market approval success

Raymond Kester
29 June 2023
Read

Interview

How a new generation of FDA reviewers can meet the future demands of cell and gene therapy

How a new generation of FDA reviewers can meet the future demands of cell and gene therapy

Deborah Hursh
1 July 2023
Read

Webinars